Antimicrobial resistance is widespread in Salmonella infections that affect millions 25 worldwide. Salmonella typhi and other Gram-negative bacterial pathogens encode an outer 26 membrane phospholipase A (OmpLA), crucial for their membrane integrity. Further, OmpLA 27 is implicated in pathogen internalization, haemolysis, acid tolerance, virulence and sustained 28 infection in human hosts. OmpLA is an attractive drug target for developing novel anti-29 microbials that attenuate virulence, as the abrogation of OmpLA encoding pldA gene causes 30 loss of virulence. Here, we present the crystal structure of Salmonella typhi OmpLA in 31 dimeric calcium bound activated state at 2.95 Å. Structure analysis suggests that OmpLA is a 32 potential druggable target. Further, we have identified and shortlisted small molecules that 33 bind at the dimer interface using structure based in silico screening, docking and molecular 34 dynamics. While it requires further experimental validation, anti-microbial discovery 35 targeting OmpLA from gram-negative pathogens offers an advantage as OmpLA is required 36 for virulence. 37 38 Keywords: Outer membrane phospholipase A (OmpLA), OmpLA, Salmonella typhi, crystal 39 structure, antibiotic resistance, antimicrobial design 40 41 42 43 44 65 strongly suggests OmpLA is not essential for growth but is a major virulence factor and 66 hence a potential drug target. Interestingly, bacterial OmpLA shows no sequence or structural 67 homology with soluble phospholipases in human, indicative of its usefulness as a unique drug 68 target. 69 4 70 Results and discussion 71 Structure determination of S. typhi OmpLA 72
Introduction 45
Salmonella typhi, a human pathogen, causes typhoid fever that affects ~ 21 million people 46 every year (WHO, Fact sheet 2018). Existing therapies include various antibiotics, misuse of 47 7 induce and stabilize the functional dimer formation of OmpLA. However, in E. coli OmpLA 145 (1QD6) the first calcium is bound by octahedral geometry through C/S152, C/R147, D/S106 146 along with three water molecules (no vacancy). The second calcium is coordinated by 147 trigonal bipyramidal geometry through C/S106, D/R147, D/S152 along with D/H2O302 (20% 148 vacancy) 15 . Each OmpLA monomer contains two aromatic belts around the β-barrel, separated by a 152 distance of 22 to 26 Å on either side of the membrane which is very close to the average 153 bacterial outer membrane thickness (Fig. 2d ). The aromatic amino acids help anchor into 154 membrane and stabilize the protein 18, 19 . Aromatic side chains in these belts are in two major 155 conformations; side chains towards the inner side of aromatic belts, located in the 156 hydrophobic environment of detergent solubilized protein, are oriented away from polar 157 solute, along the membrane plane, while the aromatic rings, particularly tyrosine with 158 hydroxyl groups, located at the detergent-polar solvent interface are oriented towards the 159 polar lipid head-solvent interface 20 as seen in Figure 2d . Aromatic π-π interactions are 160 implicated in the stability and self-assembly processes in proteins 20 . Three aromatic π-π 161 interactions are noted between F129 and W118 (4.8 Å), Y134 and Y112 (6.87 Å), Y221 and 162 W189 (4.60 Å). There are 12 tyrosine, 4 tryptophan and 6 phenylalanine residues marking the 163 aromatic belt with a predominance of tyrosine residues. These Tyrosine residues contribute to 164 the stability of OmpLA embedded in the outer membrane. The dimer has a buried surface of 1429 Å 2 which occludes 31% of the total solvent accessible 167 area (PDBePISA) 21 . The dimer interface is also stabilized by the presence of 13 hydrogen 168 bonds, 5 aromatic ring interactions and three hydrophobic patches as shown in Figure 3 . The 169 8 following hydrogen bonds are noted between A/N77(OD1): B/S168(OG) (3.7Å),
170
A/N77(ND2): B/S168(OG) (3.3Å), A/S168(OG): B/N77(OD1) (3.3Å), A/S168(OG): 171 B/N77(ND2) (3.7Å), A/s126(OG): B/D169(OD1) (2.8Å), A/S126(O): B/S172(OG) (3.5Å), OmpLA are shown in Figure S4 where the residues involved in crystal contacts are shown in In silico structure-based anti-microbial discovery targeting StOmpLA 253 To target StOmpLA with small molecular inhibitors, a thorough structural analysis of binding 254 pockets was done using the SiteMap module of Schrodinger suite, which predicts druggable 255 pockets, based on size, shape and chemical features (Table S1 ). The top ranked site (site-1) is 256 found at the dimer interface, facing the extracellular side of ( Fig. 6a, b) , and contains the Table S2 . Site-2, located right beneath site-1 in each 264 monomer, spans the buried interior space between the two monomers where the native 265 membrane lipid substrate is expected to bind. This is evident from the complex crystal Figure S6 . Residues with values more than 1 make multiple contacts with these potential 299 binders. A detailed 2D representation of an elaborate interaction pattern for more than 30%-300 time occupancy during the entire 100ns simulation is shown in Figure S7 . These results The crystal structure of calcium bound StOmpLA was determined to the resolution 2.95 Å.
307
The functional dimeric structure was used as a template to screen potential small molecule 308 binders that target the top ranked druggable pocket in the dimer interface of StOmpLA.
309
Docked complexes of top three hits; NCI97317, Alanylthreonine and Phloretin from 14 short-310 listed compounds were assessed for structural stability using 100 ns molecular dynamics 311 simulations. The data presented here provides a framework for further experimental 312 validation that will help develop therapeutics specifically targeting virulence causing 313 mechanism of Gram -negative pathogens, encoding OmpLA. This approach may help address 314 the growing problem of antibiotic resistance. Statistics for the highest-resolution shell are shown in parentheses. 
